US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

49.57

-0.3400-0.68%

Volume:10.01K

Turnover:495.65K

Market Cap:47.09M

PE:- -

High:49.72

Open:49.67

Low:49.30

Close:49.91

52wk High:56.18

52wk Low:23.81

Shares:950.00K

Float Shares:950.00K

Volume Ratio:1.42

T/O Rate:1.05%

Dividend:0.65

Dividend Rate:1.32%

ROE:--

ROA:--

PB:1.07

PE(LYR):- -

Loading ...

Overview Company News Filings

Dupixent’s Next Move: STYLE 1 Itch Study Wraps Up for Regeneron and Sanofi

GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress

Psychedelic: Optimi to initiate Phase 2 trial of psilocybin-assisted therapy

Optimi Health to initiate Phase 2 trial of psilocybin-assisted therapy for MDD

Disc Medicine presents initial results from RESTORE phase 2 trial in PV patients

BioAge Labs doses first patient in QUELL-DME study

Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial

CARDIO-TTRansform Update: What Eplontersen’s Phase 3 Completion Means for AstraZeneca Investors

Alterity Therapeutics to Spotlight MSA Program at Cantor Global Healthcare Conference

AC Immune’s New Phase 1 NLRP3 Trial Puts Inflammation Strategy in Focus

Revealed: BBC bid just £900k for £5m Commonwealth Games TV rights

Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP

Latigo Biotherapeutics initiated with a Buy at Goldman Sachs

AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan

BioNTech Stock (BNTX) Is Tumbling on Friday – Here’s Why

Nepal Flood Disaster Claims 469 Lives, 977 Missing; Government Confirms Glacial Collapse Triggered Catastrophic Flooding

NeuroThera Labs Hires European IR Firm to Expand Investor Reach

Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets

BNK Banking Corporation Plans FY26 Results and Strategy Briefing

BNK Bank Takes Goodwill Hit But Grows Margins and Loan Book in FY26

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/BBC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Clinical Trials ETF","latestPrice":49.57,"timestamp":1789150559690,"preClose":49.91,"halted":0,"volume":10007,"delay":0,"changeRate":-0.006812262071729039,"floatShares":950000,"shares":950000,"eps":0,"marketStatus":"Trading","change":-0.34,"latestTime":"09-11 14:23:55 EDT","open":49.67,"high":49.72,"low":49.3,"amount":495651.61343,"amplitude":0.008415,"askPrice":49.75,"askSize":100,"bidPrice":49.15,"bidSize":500,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":49.91,"sharesOutstanding":900004,"nav":51.382,"aum":48812941.17,"dividendRate":0.013193,"bidAskSpread":0.001886,"postHourTrading":{"tag":"盘后","latestPrice":49.91,"preClose":49.91,"latestTime":"19:30 EDT","volume":22,"amount":1105.95,"timestamp":1789083026465,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.422085,"impliedVol":0.3013,"impliedVolPercentile":0.2829},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","floatShares":950000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.422085,"shares":950000,"dividePrice":0.654,"high":49.72,"amplitude":0.008415,"preClose":49.91,"low":49.3,"week52Low":23.81,"pbRate":"1.07","week52High":56.18,"institutionHeld":0,"latestPrice":49.57,"committee":0.666667,"eps":0,"divideRate":0.013193,"volume":10007,"delay":0,"ttmEps":0,"open":49.67,"prevYearClose":38.56,"prevWeekClose":53.71,"prevMonthClose":53.05,"prevQuarterClose":52.6861,"fiveDayClose":53.39,"twentyDayClose":52.3537,"sixtyDayClose":43.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBC\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBC","amount":0.65544,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2024-12-20","symbol":"BBC","amount":0.23947,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-27"},{"date":"2023-12-20","symbol":"BBC","amount":0.0823,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","recordDate":"2023-12-29","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-29","value":0.0823,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-27","value":0.23947,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-29","value":0.65544,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666057576","title":"Dupixent’s Next Move: STYLE 1 Itch Study Wraps Up for Regeneron and Sanofi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666057576","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666057576?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:30","pubTimestamp":1789144227,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals ($REGN), Sanofi ($SNYNF) announced an update on their ongoing clinical study. The STYLE 1 study is a Phase 3 trial run by...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dupixents-next-move-style-1-itch-study-wraps-up-for-regeneron-and-sanofi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dupixents-next-move-style-1-itch-study-wraps-up-for-regeneron-and-sanofi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNYNF","BBC","PSIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666446516","title":"GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2666446516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666446516?lang=en_us&edition=fundamental","pubTime":"2026-09-11 05:02","pubTimestamp":1789074144,"startTime":"0","endTime":"0","summary":"The latest update is out from GeoVax Labs ( ($GOVX) ). GeoVax Labs, Inc., a clinical-stage biotechnology firm listed on Nasdaq as GOVX, develops va...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/geovax-updates-nasdaq-listing-amid-ongoing-clinical-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/geovax-updates-nasdaq-listing-amid-ongoing-clinical-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","LNGR","IEIH","AGNG","BK4588","PRGS","JDOC","RSPH","IBB","LU2065732104.USD","SYNB","BBP","FHLC","BK4585","DARP","BBC","FWD","BK4097","LCLG","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666659418","title":"Psychedelic: Optimi to initiate Phase 2 trial of psilocybin-assisted therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2666659418","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666659418?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:50","pubTimestamp":1789051821,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study initiation plans, a Breakth...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psychedelic-optimi-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psychedelic-optimi-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666910405","title":"Optimi Health to initiate Phase 2 trial of psilocybin-assisted therapy for MDD","url":"https://stock-news.laohu8.com/highlight/detail?id=2666910405","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666910405?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:25","pubTimestamp":1789050337,"startTime":"0","endTime":"0","summary":"Optimi Health (OPTH) announces plans to initiate a multisite Phase 2 clinical trial evaluating psilocybin-assisted therapy for individuals with maj...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimi-health-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-for-mdd-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimi-health-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-for-mdd-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","OPTH","HYLG","MEDX","ABVC","BK4007","IDNA","BK4139","PSIL","BBC","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666554185","title":"Disc Medicine presents initial results from RESTORE phase 2 trial in PV patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2666554185","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666554185?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:05","pubTimestamp":1788998708,"startTime":"0","endTime":"0","summary":"Disc Medicine (IRON) “presented positive initial results from the RESTORE-PV Phase 2 trial of DISC-3405 in patients with polycythemia vera. The dat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/disc-medicine-presents-initial-results-from-restore-phase-2-trial-in-pv-patients-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/disc-medicine-presents-initial-results-from-restore-phase-2-trial-in-pv-patients-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DISC","IRON","BBC","PSIL","BK4139","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665037847","title":"BioAge Labs doses first patient in QUELL-DME study","url":"https://stock-news.laohu8.com/highlight/detail?id=2665037847","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665037847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:35","pubTimestamp":1788870924,"startTime":"0","endTime":"0","summary":"BioAge Labs (BIOA) announced that the first participant has been dosed in QUELL-DME, a randomized, controlled Phase 2 trial evaluating once-daily o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-doses-first-patient-in-quell-dme-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-doses-first-patient-in-quell-dme-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BK4007","BIOA","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327821","title":"Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327821","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327821?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:11","pubTimestamp":1788865885,"startTime":"0","endTime":"0","summary":"Bristol Myers (BMY) announced positive Phase 2 results from the registrational QUINTESSENTIAL trial of arlocabtagene autoleucel in adult patients w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-arlocabtagene-autoleucel-shows-positive-results-in-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-arlocabtagene-autoleucel-shows-positive-results-in-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1868837300.USD","LU2133065610.SGD","BK4534","LU0868494617.USD","LU1718418525.SGD","MYE","BK4585","BBC","LU1093756325.SGD","LU2125154935.USD","BMY","IE0002141913.USD","LU0114720955.EUR","LU1236620834.HKD","LU1093756168.USD","LU1868836914.USD","LU1670711123.USD","LU1670710588.SGD","LU0985481810.HKD","BK4588","LU0237698245.USD","BK4559","LU2360032135.SGD","LU1989771016.USD","IE00BFTCPJ56.SGD","LU1074936037.SGD","LU1430594728.SGD","LU0267386448.USD","LU1983299246.USD","LU1883839398.USD","IE00BJJMRZ35.SGD","LU2596442595.SGD","LU1670710661.SGD","LU1236620750.USD","LU0432979614.USD","BK4126","LU1261432733.SGD","LU0061475181.USD","LU1032466523.USD","LU0456855351.SGD","IE00BSNM7G36.USD","LU2242652126.USD","LU0225284248.USD","LU0321505868.SGD","LU1291159041.SGD","IHE","IE0009355771.USD","LU0882574055.USD","PSIL","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664338805","title":"CARDIO-TTRansform Update: What Eplontersen’s Phase 3 Completion Means for AstraZeneca Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664338805","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664338805?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:30","pubTimestamp":1788453041,"startTime":"0","endTime":"0","summary":"AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The CARDIO-TTRansform study is a Phase 3 trial that tests eplontersen in p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cardio-ttransform-update-what-eplontersens-phase-3-completion-means-for-astrazeneca-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cardio-ttransform-update-what-eplontersens-phase-3-completion-means-for-astrazeneca-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BBC","BK4211","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664214842","title":"Alterity Therapeutics to Spotlight MSA Program at Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664214842","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664214842?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:47","pubTimestamp":1788392845,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics ( ($AU:ATH) ) has provided an update. Alterity Therapeutics, a clinical-stage biotechnology company developing disease-modify...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-to-spotlight-msa-program-at-cantor-global-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-to-spotlight-msa-program-at-cantor-global-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","AGNG","XT","BK4137","LENZ","JDOC","LNGR","IEIH","IBB","BK4585","LU0029874061.USD","BBC","BK4539","LU0128526141.USD","XBI","DARP","LABU","BBP","BK4007","BK4139","RSPH","BK4588","FHLC","SYNB","FWD","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664435478","title":"AC Immune’s New Phase 1 NLRP3 Trial Puts Inflammation Strategy in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2664435478","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664435478?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:31","pubTimestamp":1788366665,"startTime":"0","endTime":"0","summary":"AC Immune ($ACIU) announced an update on their ongoing clinical study. AC Immune SA is running a Phase 1 trial called a single-center, double-blind...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ac-immunes-new-phase-1-nlrp3-trial-puts-inflammation-strategy-in-focus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ac-immunes-new-phase-1-nlrp3-trial-puts-inflammation-strategy-in-focus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664958418","title":"Revealed: BBC bid just £900k for £5m Commonwealth Games TV rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2664958418","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664958418?lang=en_us&edition=fundamental","pubTime":"2026-09-02 12:00","pubTimestamp":1788321600,"startTime":"0","endTime":"0","summary":"The BBC offered 91 per cent less for the Glasgow Commonwealth Games than they paid for Birmingham in 2022 Commonwealth Games chiefs took flak for agreeing a broadcast deal with TNT Sports that put it behind a paywall for the first time in 72 years – but City AM can reveal the BBC offered less than 1m for the rights.The BBC’s bid of around 900,000 represented a 91 per cent decrease on the 10m the organisation paid for the rights to broadcast the 2022 Commonwealth Games in Birmingham.TNT Sports, owned by Warner Bros Discovery, ended up paying around 5m to become the competition’s official UK partner, showing all the action on its linear TV channel and streaming it on HBO Max. TNT Sports costs between 25.99 and 30.99 per month, while HBO Max is available for 4.99 per month.","market":"fut","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/09/GettyImages-2288636445-1.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/09/GettyImages-2288636445-1.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/revealed-bbc-bid-just-900k-for-5m-commonwealth-games-tv-rights/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/revealed-bbc-bid-just-900k-for-5m-commonwealth-games-tv-rights/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855897","title":"Upstream Bio Announces Pivotal Phase 3 Development Plans for Verekitug in Both Severe Asthma and CRSwNP","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855897","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855897?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"– Following productive FDA discussions, Upstream Bio will study 400 mg of verekitug administered every 12 weeks, versus placebo, in severe asthma and CRSwNP with one pivotal Phase 3 trial in each indi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353967/0/en/upstream-bio-announces-pivotal-phase-3-development-plans-for-verekitug-in-both-severe-asthma-and-crswnp.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC","09766","PSIL","07766","LABU","09366","TSYY","TSLZ","TESC","TSLY","TLA","TSLW","TSLQ","TSL","TESL","TEST","TSLT","CRSH","TSLP","TSLL","TSLG","TSLI","07366","ELOL","TSDD","TSLR","TSII","TSLS","TSLO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883471","title":"Latigo Biotherapeutics initiated with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883471","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883471?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:30","pubTimestamp":1788251407,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of Latigo Biotherapeutics (LTGO) with a Buy rating and $73 price target Latigo is clinical-stage biotechnology com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/latigo-biotherapeutics-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/latigo-biotherapeutics-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4504","IE0002270589.USD","LU1868836757.USD","FWD","LU0210536198.USD","LU0868494617.USD","LU1668664300.SGD","LU1868837136.USD","LU1868836914.USD","LU2237443622.USD","IEIH","FHLC","LU0106831901.USD","JDOC","IE0004091025.USD","LNGR","LU1894683348.USD","SYNB","BK4585","BK4127","IBB","LU0942090050.USD","AGNG","LU1868836591.USD","LU2896262040.SGD","BK4552","BK4007","IE0004086264.USD","LU2237443895.HKD","LU2471134796.USD","LU0096364046.USD","LU2237443382.USD","LU2237443549.SGD","LU0345770993.USD","LU2471134523.USD","GSX","XT","IE00BSNM7G36.USD","BBC","LU1144417596.USD","IE00BFXG1179.USD","DARP","BK4516","IE00B19Z3B42.SGD","LU0251131958.USD","LU2237438978.USD","RSPH","LTGO","BBP","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663009747","title":"AbbVie Targets Rare Blood Disorder With New Phase 3 Etentamig Trial Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2663009747","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663009747?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:31","pubTimestamp":1787934678,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) has posted a new Phase 3 trial plan for its drug etentamig in amy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-rare-blood-disorder-with-new-phase-3-etentamig-trial-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvie-targets-rare-blood-disorder-with-new-phase-3-etentamig-trial-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IXJ","IE0002141913.USD","XLV","SG9999011175.SGD","IE0000B7K699.USD","LU2112291526.USD","IE00B42XCP33.USD","IE000BZT7R73.USD","LU1267930490.SGD","LU1496350502.SGD","JDOC","PSIL","MEDX","LU2129689431.USD","LU0795875169.SGD","LU1934455194.USD","IE00BSNM7G36.USD","BK4585","LU1496350171.SGD","LU1244550494.USD","IE00B2B36J28.USD","LU2089283258.USD","GLAM","ABBV","LU0726765562.USD","IE000SO60NU8.SGD","LU1670627923.USD","LU1989772840.SGD","LU2237443465.HKD","IE00BBT3K403.USD","IE00BLSP4239.USD","LU0029864427.USD","LU0057025933.USD","PPH","IYH","LU0868494708.USD","AGNG","RXL","LU1074936037.SGD","IE0004445239.USD","LU0320765646.SGD","BK4550","LU0942090050.USD","TRUH","FHLC","LU0985320562.USD","VHT","PJP","FTXH","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663547097","title":"BioNTech Stock (BNTX) Is Tumbling on Friday – Here’s Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2663547097","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663547097?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:15","pubTimestamp":1787933700,"startTime":"0","endTime":"0","summary":"BioNTech ($BNTX) shares declined as much as 10% on Friday after the company said it has ended a key Phase 2 trial for its mRNA colorectal cancer va...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/biontech-stock-bntx-is-tumbling-on-friday-heres-why?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/biontech-stock-bntx-is-tumbling-on-friday-heres-why?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4139","BK4535","BK4568","BBC","BNTX","BK4585","BK4588","BK4548","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136125076","title":"Nepal Flood Disaster Claims 469 Lives, 977 Missing; Government Confirms Glacial Collapse Triggered Catastrophic Flooding","url":"https://stock-news.laohu8.com/highlight/detail?id=1136125076","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136125076?lang=en_us&edition=fundamental","pubTime":"2026-08-28 14:10","pubTimestamp":1787897453,"startTime":"0","endTime":"0","summary":"Nepal has been struck by a devastating flood disaster, with the death toll climbing to 469 and 977 people still unaccounted for. The catastrophic event has also impacted the tourism sector...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662403754","title":"NeuroThera Labs Hires European IR Firm to Expand Investor Reach","url":"https://stock-news.laohu8.com/highlight/detail?id=2662403754","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662403754?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:02","pubTimestamp":1787878968,"startTime":"0","endTime":"0","summary":"NeuroThera Labs Inc. ( ($TSE:NTLX) ) has issued an announcement. NeuroThera Labs Inc., a clinical-stage biotech subsidiary of SciSparc Ltd. listed ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurothera-labs-hires-european-ir-firm-to-expand-investor-reach?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurothera-labs-hires-european-ir-firm-to-expand-investor-reach?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","XBIX","NVIB","EPV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662084187","title":"Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2662084187","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662084187?lang=en_us&edition=fundamental","pubTime":"2026-08-28 00:31","pubTimestamp":1787848308,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has started a new Phase 1 trial called “A Phase 1, Open-La...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-amg-691-phase-1-trial-targets-key-growth-in-asian-markets?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-amg-691-phase-1-trial-targets-key-growth-in-asian-markets?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","IE0002141913.USD","LU0889565916.HKD","TBXU","LU1061106388.HKD","PBE","IE00B4R5TH58.HKD","IBB","IE00B2B36J28.USD","LU1023059063.AUD","AMGN","LU2242646821.SGD","SG9999001440.SGD","BBC","BK4581","LU0058720904.USD","PJP","LU1057294990.SGD","LU1571399168.USD","BK4585","BK4566","LU2089984988.USD","BK4534","LU2242652126.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4139","IE00BJJMRZ35.SGD","BK4599","LU0868494617.USD","LU1983299246.USD","LU0122379950.USD","LU2112291526.USD","BBH","BK4533","IE0009355771.USD","BK4588","BIB","IBBQ","LU0289739699.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662472330","title":"BNK Banking Corporation Plans FY26 Results and Strategy Briefing","url":"https://stock-news.laohu8.com/highlight/detail?id=2662472330","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662472330?lang=en_us&edition=fundamental","pubTime":"2026-08-27 07:08","pubTimestamp":1787785731,"startTime":"0","endTime":"0","summary":"BNK Banking Corporation Limited ( ($AU:BBC) ) has provided an update. BNK Banking Corporation Limited, branded as “The Bank for Enterprising Austra...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bnk-banking-corporation-plans-fy26-results-and-strategy-briefing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bnk-banking-corporation-plans-fy26-results-and-strategy-briefing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662572354","title":"BNK Bank Takes Goodwill Hit But Grows Margins and Loan Book in FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2662572354","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662572354?lang=en_us&edition=fundamental","pubTime":"2026-08-27 07:08","pubTimestamp":1787785715,"startTime":"0","endTime":"0","summary":"BNK Banking Corporation Limited ( ($AU:BBC) ) has issued an announcement. BNK Banking Corporation Limited reported a statutory net loss of $3.7 mil...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bnk-bank-takes-goodwill-hit-but-grows-margins-and-loan-book-in-fy26?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bnk-bank-takes-goodwill-hit-but-grows-margins-and-loan-book-in-fy26?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":137,"code":"91000000","status":"200"}]}}